EGFR and neoplasm: The results suggested that the EGFR/CD3 BsAb and EGFR McAb were able to direct CD3 positive CIK cells to tumor cells and the ability of the EGFR/CD3 BsAb to target CIK cells to tumor cells was higher than that of EGFR McAb.